ClusterOS Diagnostic Profile

London Life Sciences Health

London, United Kingdom Extraction-Narrative 110 evidence items

London Life Sciences Health runs on 110 evidence items (London Life Sciences Health UKRI grants: 1958 grants, £1709m total, 248 disti). The diagnostic resolves a Extraction-Narrative configuration at MEDIUM confidence.

9
Active stalls
1
Stacks identified
110
Evidence items
6
Leverage timeline (mo)
S1
Re-proving Instead of Narrowing
medium
S2
Coordinating Instead of Deciding
low
S3
Forgiving Instead of Redesigning
indeterminate
S4
Extracting Without Reinvesting
high
S5
Mediating Instead of Coupling
low
Stabilising Around Incumbents
medium
S7
Narrating Instead of Testing
low
S8
Scaling Activity Instead of Throughput
high
S9
Waiting for Permission
indeterminate
Stack 01 S4 · S7

Value extraction events generate narrative about ecosystem success; narrative legitimises continued extraction by framing it as ecosystem contribution; uncertainty about whether extraction is harmful absorbed by the success narrative.

"A probe could test whether London & Partners or BIA (industry promotion bodies) reporting separately on value extraction (equity capital destinations, acquirer geographies, talent outflows) and value retention (licensing revenue to anchor institutions, follow-on collaborations, talent circulation) might perturb the extraction-narrative configuration by making attribution...

6-12 months

Leverage hypotheses are testable perturbations, not prescriptions. Where demand-side behaviour is weakly visible, the correct move is observation — improving visibility before attempting change.

What happens next
This is a structural profile, not a full diagnostic.

A full ClusterOS diagnostic adds actor questionnaire data, working sessions, and anchor interviews — producing higher-confidence stall identification, board-ready stack analysis, and leverage hypotheses calibrated to your specific context.

London Life Sciences Health
Free Pulse Check → Request a Diagnostic →